APYX: Apyx Medical Corp

FinancialsDividends

$2.10

-0.06

(-2.78%)

As of 07/11/2025 5:00 PM ET • Disclaimer
Powered by Stocksift.com

100%

APYX Performance Snapshot

1-Week Chg

-8.30%

1-Month Chg

19.32%

3-Month Chg

119.21%

6-Month Chg

32.08%

1-Year Chg

57.89%

Year-To-Date Chg

33.33%

Beta 1-Year

2.50

Beta 5-Year

1.97

Volatility (10-Day)

5.84%

APYX Technical Snapshot

Datesorted descending
Close
Change 1D
Open
High
Low
Typical
Volume

2025-07-11

$2.10

-$0.06 (-2.78%)

$2.16

$2.16

$2.09

$2.12

33.00K ($69.30K)

2025-07-10

$2.16

-$0.12 (-5.26%)

$2.26

$2.35

$1.98

$2.16

235.00K ($507.60K)

2025-07-09

$2.28

-$0.09 (-3.8%)

$2.33

$2.47

$2.25

$2.33

98.00K ($223.44K)

2025-07-08

$2.37

-$0.21 (-8.14%)

$2.72

$2.72

$2.37

$2.49

124.00K ($293.88K)

2025-07-07

$2.58

$0.29 (12.66%)

$2.35

$2.73

$2.30

$2.54

269.00K ($694.02K)

2025-07-03

$2.29

$0.14 (6.51%)

$2.17

$2.35

$2.16

$2.27

78.50K ($179.76K)

2025-07-02

$2.15

-$0.09 (-4.02%)

$2.22

$2.27

$2.15

$2.19

29.60K ($63.64K)

2025-07-01

$2.24

-$0.01 (-0.44%)

$2.24

$2.27

$2.12

$2.21

90.00K ($201.60K)

2025-06-30

$2.25

$0.09 (4.17%)

$2.17

$2.27

$2.15

$2.22

53.00K ($119.25K)

2025-06-27

$2.16

-$0.08 (-3.57%)

$2.23

$2.25

$2.10

$2.17

54.00K ($116.64K)

APYX Financial Snapshot

Balance Sheet

(USD)

2025 Q1

Y/Y CHANGE

  • Cash and equivalents

    $31.01M

    -16.82%

  • Total assets

    $60.16M

    -14.92%

  • Total liabilities

    $49.52M

    -1.46%

  • Total investments

    $0

    0%

  • Shareholders' equity

    $10.51M

    -48.10%

  • Book value per share

    $0.28

    -52.48%

Income Statement

(USD)

2025 Q1

Y/Y CHANGE

  • Revenue

    $9.43M

    -7.95%

  • Net income

    -$4.15M

    45.22%

  • Operating expense

    $8.72M

    -30.63%

  • Gross profit

    $5.67M

    -4.77%

  • EBITDA

    -$2.56M

    56.88%

  • Earnings per share

    -$0.10

    54.55%

Cash Flow

(USD)

2025 Q1

Y/Y CHANGE

  • Net change in cash

    -$730.00K

    88.54%

  • Cash from operations

    -$702.00K

    88.93%

  • Cash from investing

    -$55.00K

    -57.14%

  • Cash from financing

    $25.00K

    600.00%

  • Free cash flow

    -$757.00K

    88.13%

  • Free cash flow per share

    -$0.02

    89.13%

Metrics

(USD)

2025 Q1

Y/Y CHANGE

  • Market capitalization

    $51.78M

    9.89%

  • Enterprise value

    $58.80M

    40.12%

  • Shares outstanding

    37.79M

    9.09%

  • Profit margin

    -44.00%

    40.54%

  • Gross margin

    60.10%

    3.44%

  • EBITDA margin

    -27.20%

    53.10%

Dividends

(USD)

2025 Q1

Y/Y CHANGE

  • Dividend yield

    0%

    0%

  • Dividends per share

    $0

    0%

  • Dividend growth

    -

    -

  • Payout ratio

    0%

    0%

  • Coverage ratio

    -

    -

  • Current ratio

    5.45

    -7.06%

View Financial Statements